We're Horizon, a global biotechnology company driven by a simple idea: we believe that science and compassion must work together to transform lives.
Location: United States, Illinois, Deerfield
Employees: 51-200
Total raised: $370K
Investors 4
| Date | Name | Website |
| - | NaviMed Ca... | navimed.co... |
| 14.05.2021 | EW Healthc... | ewhealthca... |
| - | Hercules C... | htgc.com |
| - | Quaker Par... | quakerpart... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.10.2022 | - | $150K | - |
| 27.04.2022 | - | $220K | - |
Mentions in press and media 4
| Date | Title | Description |
| 21.08.2024 | New Horizon Aircraft Announces Closing of $2.9 Million Public Offering | TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- New Horizon Aircraft (NASDAQ: HOVR), today closed its previously announced underwritten public offering of (i) 2,800,000 of its Class A ordinary shares, no par value per share, and accompanying war... |
| 19.06.2012 | Horizon Pharma Enters into Exclusive Agreement with Grunenthal for Commercialization of DUEXIS® in Latin America | DEERFIELD, Ill., June 19, 2012 /PRNewswire/ — Horizon Pharma, Inc. (NASDAQ: HZNP) a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases... |
| 05.04.2012 | GI-safe aspirin leads PLx’s pipeline of improved safety NSAIDs | A second product is an ibuprofen formulation that’s also in the clinical stage. Zimmerman said it’s demonstrated bioequivalence with over-the-counter and prescription doses of ibuprofen for anti-inflammatory and pain relief, and a pilot end... |
| - | GI-safe aspirin leads PLx’s pipeline of improved safety NSAIDs | Nonsteroidal anti-inflammatory drugs are one of the most prescribed drug classes, but their gastrointestinal toxicity is now widely cited and a market for less-harmful versions of these drugs has emerged over the past decade and a half. Now... |